Neurology News
Editor's Choice (JNS Vol 454): AI and machine learning in aneurysmal subarachnoid hemorrhage
20 Nov 2023
Aneurysmal subarachnoid hemorrhage (SAH) is a subtype of hemorrhagic stroke with thirty-day mortality as high as 40%. Given the expansion of Machine Learning (ML) and Artificial intelligence (AI) methods in health care, SAH patients desperately need an integrated AI system that detects, segments, and supports clinical decisions based on presentation and severity.
High biological age may increase the risk of dementia and stroke
5 Nov 2023
People who have a higher biological age than their actual chronological age have a significantly increased risk of stroke and dementia, especially vascular dementia. These are the results of a study from Karolinska Institutet in Sweden published in the Journal of Neurology, Neurosurgery and Psychiatry.
Editor's Choice (JNS Vol 453): AI and Deep Learning in Diagnosis and Analysis
23 Oct 2023
Deep learning analysis of UPLC-MS/MS-based metabolomics data to predict Alzheimer's disease, and Invoking AI for diagnosis: Art at the cutting edge of science
President of African Academy of Neurology Calls for Urgent, Unified Action to Address Lack of Trained Neurologists Throughout
19 Oct 2023
Africa currently experiences some of the most extreme shortages of neurologists and health care funding and some of the highest rates of disability due to neurological disorders in the world. Dr. Augustina Charway-Felli, president of the African Academy of Neurology, recently proposed a plan for addressing these disparities by emphasizing regional training to increase the number of neurologists throughout Africa and prioritizing education for primary care providers and non-specialists.
WHO outlines considerations for regulation of artificial intelligence for health
19 Oct 2023
The World Health Organization (WHO) has released a new publication listing key regulatory considerations on artificial intelligence (AI) for health. The publication emphasizes the importance of establishing AI systems’ safety and effectiveness, rapidly making appropriate systems available to those who need them, and fostering dialogue among stakeholders, including developers, regulators, manufacturers, health workers, and patients.
eNS Editor's Choice: Gender parity in high impact neurology journals
19 Oct 2023
Although female representation has been growing among physicians, women continue to be underrepresented in neurology, particularly regarding academic research in authorship and leadership. Analyzing recent trends in high-impact neurology journals highlights the underrepresentation of women and helps explore barriers to female representation in academic neurology.
New Research on Drastically Reducing Long-Term Disability After a Stroke
19 Oct 2023
Stroke is a leading cause of disability worldwide, and over 15 million people suffer a stroke each year—yet 80% of strokes are preventable. There are treatments that can successfully treat a stroke in progress and reduce long-term disability, but they must be given soon after the start of a stroke. Because global health care systems are drastically under-resourced, these treatments are often not available to the people who need them.
Kathy Oliver Champions Global Action for Patient Organizations at the 26th World Congress of Neurology
18 Oct 2023
There is a growing call to embrace patient engagement in the world of health care, and Kathy Oliver, chair of the International Brain Tumour Alliance (IBTA), is one of many patient advocates at the vanguard of this movement around the world. Patient organizations like IBTA are increasingly at the forefront of patient engagement across various health care domains, including in the design of clinical trials, drug development, health care policy, pricing and reimbursement decisions, and regulatory issues.
Dr. Huda Zoghbi Reveals New Research Into the Mechanisms Driving Rett Syndrome at the 2023 World Congress of Neurology
18 Oct 2023
Huda Zoghbi, MD, professor of molecular and human genetics, Baylor College of Medicine, has made a groundbreaking discovery in the field of neurology. Her research shows that mutations in the MECP2 gene are responsible for causing Rett syndrome, a childhood disorder that primarily affects females and is diagnosed in around 1 in 10,000 girls born each year.
